Latest news with #MiamiProjecttoCureParalysis
Yahoo
03-06-2025
- Business
- Yahoo
Neuralink secures $650m in Series E to advance brain implant technology
Neuralink has secured $650m in a Series E financing round, marking a milestone in the advancement of its brain implant technology. This latest financial boost is aimed at expanding the reach of the company's devices, which are said to restore independence for individuals with severe medical conditions. The round saw contributions from a host of investors, including DFJ Growth, ARK Invest, Founders Fund, Human Capital, G42, Lightspeed, QIA, Thrive Capital, Sequoia Capital, Valor Equity Partners, and Vy Capital. Since its Series D round in August 2023, Elon Musk's Neuralink has been advancing the development of brain interfaces. According to the company, currently, five people with severe paralysis utilise Neuralink's technology to control various digital and physical devices using their thoughts alone. The company's trials are underway at neurosurgical care institutions across three countries on two continents. These comprise the Miami Project to Cure Paralysis at the University of Miami, US, the Barrow Neurological Institute, US, the Cleveland Clinic Abu Dhabi, and the University Health Network (Toronto Western Hospital), Canada. Neuralink invested in enhancing the device's interaction with a greater number of neurons and brain areas to unveil new potential dimensions. The fresh funding is set to expedite the company's drive to broaden access to patients and develop future solutions that bridge the gap between biological intelligence and AI. Musk has shifted focus back to his ventures, including Neuralink, Tesla, SpaceX, and xAI, after stepping down as a special adviser to US President Donald Trump. Last November, Neuralink secured approval for the CONVOY trial to study the brain implant with an assistive robotic arm, alongside the PRIME study in the US. Additionally, Health Canada approved Neuralink's first global trial, CAN-PRIME, to assess its implantable device, with the aforementioned University Health Network hospital selected as the trial site. Recently, the US Food and Drug Administration granted the company's brain-computer interface breakthrough device designation for treating individuals with severe speech impairment. "Neuralink secures $650m in Series E to advance brain implant technology" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
03-06-2025
- Business
- Yahoo
Neuralink secures $650m in Series E to advance brain implant technology
Neuralink has secured $650m in a Series E financing round, marking a milestone in the advancement of its brain implant technology. This latest financial boost is aimed at expanding the reach of the company's devices, which are said to restore independence for individuals with severe medical conditions. The round saw contributions from a host of investors, including DFJ Growth, ARK Invest, Founders Fund, Human Capital, G42, Lightspeed, QIA, Thrive Capital, Sequoia Capital, Valor Equity Partners, and Vy Capital. Since its Series D round in August 2023, Elon Musk's Neuralink has been advancing the development of brain interfaces. According to the company, currently, five people with severe paralysis utilise Neuralink's technology to control various digital and physical devices using their thoughts alone. The company's trials are underway at neurosurgical care institutions across three countries on two continents. These comprise the Miami Project to Cure Paralysis at the University of Miami, US, the Barrow Neurological Institute, US, the Cleveland Clinic Abu Dhabi, and the University Health Network (Toronto Western Hospital), Canada. Neuralink invested in enhancing the device's interaction with a greater number of neurons and brain areas to unveil new potential dimensions. The fresh funding is set to expedite the company's drive to broaden access to patients and develop future solutions that bridge the gap between biological intelligence and AI. Musk has shifted focus back to his ventures, including Neuralink, Tesla, SpaceX, and xAI, after stepping down as a special adviser to US President Donald Trump. Last November, Neuralink secured approval for the CONVOY trial to study the brain implant with an assistive robotic arm, alongside the PRIME study in the US. Additionally, Health Canada approved Neuralink's first global trial, CAN-PRIME, to assess its implantable device, with the aforementioned University Health Network hospital selected as the trial site. Recently, the US Food and Drug Administration granted the company's brain-computer interface breakthrough device designation for treating individuals with severe speech impairment. "Neuralink secures $650m in Series E to advance brain implant technology" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Miami Herald
28-04-2025
- Automotive
- Miami Herald
Why parking is changing at a Miami hospital, and how it could affect you
Garage renovations have made parking a challenge at Miami's Jackson Memorial Hospital. Parts of Jackson's garages are shut down here and there for repairs, leaving fewer parking spaces available for patients, visitors and workers. But some relief may be on the way. As the renovation of two garages nears the finish line, Jackson Health plans to strike a deal with Miami Dade College to rent employee parking spaces inside a nearby garage to help ease parking problems. The move comes as Jackson expects to start renovations on two other parking garages this year on its shared campus with the University of Miami Miller School of Medicine. Here's what to know: What's changing with Jackson Health parking? Two parking garages will have their repairs completed by the end of the year as renovations start at Jackson's two other garages. The renovations are part of a county-mandated 30-year recertification process to ensure buildings are structurally safe. The expected timeline: ▪ Ongoing repairs at the Red Garage, 901 NW 17th St, are expected to be completed in May, according to the health system. Red Garage is next to Holtz Children's Hospital and is across from UHealth's Bascom Palmer Eye Institute. Jackson Memorial, Ryder Trauma Center and the Miami Transplant Institute are also nearby. ▪ Repairs at the Green Garage, 1140 NW 16th St., are expected to be completed by the end of the year. The Green Garage is across from the grassy area on Jackson's campus where food trucks often set up, and is a short walk from the Christine E. Lynn Rehabilitation Center for the Miami Project to Cure Paralysis. It's also near a Metrorail station and the future site of Jackson's affordable workforce housing complex. ▪ The Yellow Garage, 1801 NW Ninth Ave., which is across from Ryder Trauma and in the same building as the Miami Transplant Institute, will undergo repairs starting in the fall. Repairs will begin shortly after at the Blue Garage, 1001-1167 NW 19th St. is next to the plot of land of a future Jackson ER that's expected to be one of the largest in the nation. Are the garages safe to park? 'It has been confirmed that the garages are structurally safe' for people to park in while repairs are underway, Jackson Health spokeswoman Krysten Brenlla said in an email to the Miami Herald. What's the Jackson-MDC parking deal? The Public Health Trust, which governs Miami-Dade's public hospital system, gave the green light Friday for Jackson to negotiate and finalize a parking deal with MDC. Under the agreement, taxpayer-funded Jackson would rent 400 parking spaces from MDC's neighboring medical campus for at least a year to 'alleviate the significant parking shortage for Jackson employees' as the health system's parking garages undergo repairs. About half of Jackson's more than 14,800 full-time employees work at the main Miami campus. The MDC garage parking spaces would be for Jackson workers only. Jackson would pay the college $288,000 a year for 200 covered and 200 uncovered parking spaces, along with a one-time $6,300 set-up fee to get employee access cards and placards, according to a report sent to the Public Health Trust. The MDC garage, 1000 NW Second Ave., is a short walk from Jackson's Ryder Trauma Center and other health facilities, including the Miami Transplant Institute, Holtz Children's Hospital and UHealth's Bascom Palmer Institute. Jackson workers can still park in Jackson's four garages. But it's possible the new MDC parking option for employees will free spaces at Jackson's four parking garages for patients. Patients should still be early for appointments early to avoid traffic and parking delays.
CBS News
27-01-2025
- Health
- CBS News
Can Elon Musk's brain chip help cure paralysis? Here's what you need to know
MIAMI - Elon Musk's Neuralink brain-computer interface is now at the forefront of paralysis research, with the University of Miami's Miller School of Medicine chosen as the second U.S. site for its clinical trial. The Miami Project to Cure Paralysis has partnered with Neuralink to test a revolutionary device that could allow individuals with paralysis to control external devices using only their thoughts. "This is a huge deal," said Dr. Jonathan Jagid, a neurosurgeon and principal investigator for Neuralink at the University of Miami. "What Neuralink has designed is aligned with the Miami Project's mission to improve the lives of people living with paralysis." What the study promises The Neuralink PRIME Study will test the safety and functionality of the N1 Implant, a wireless brain-computer interface (BCI) designed to restore autonomy for individuals who have lost mobility due to conditions like spinal cord injury or ALS. "This device has the potential to be a game-changer for individuals living with these challenges," said Dr. Jagid. "It could improve their quality of life by restoring their ability to interact with the outside world." The N1 Implant uses ultra-thin electrode threads, surgically placed with Neuralink's R1 Robot, to create a digital connection between the brain and external devices such as computers. This link allows individuals to control devices without any physical movement. "By recording activity in specific areas of the brain that control movement, this device can translate thoughts into action," explained Dr. Jagid. How it works When a person thinks about moving, specific areas of their brain light up with neuronal activity. The Neuralink device taps into these areas with micrometer precision, using electrode threads to capture signals and send them wirelessly to external devices. "What's groundbreaking is how small and precise this device is," said Dr. Jagid. "It's just a little larger than a quarter, yet it holds life-changing technology." The trials, which began with a focus on safety and functionality, have already shown promising results in early patients. However, researchers emphasize that the technology is still in its early stages. "Right now, we're taking baby steps, but the future looks incredibly bright," said Dr. Jagid. "We hope this technology will soon allow people to control everyday devices in their homes, improving independence." What is next? While widespread availability is still years away, Dr. Jagid said the pace of innovation at Neuralink is accelerating. "With a company like Neuralink, things move rapidly," he said. "We're not too far from seeing this technology become transformative in the daily lives of individuals with paralysis." The procedures will be carried out at UHealth Tower, with a team of neurosurgeons, engineers, and scientists collaborating to oversee the implant surgeries and patient progress. "This trial showcases the potential of combining cutting-edge technology with medical expertise," said Dr. W. Dalton Dietrich, scientific director of The Miami Project. How to be a part of the study Neuralink is seeking participants who have limited or no use of their hands due to cervical spinal cord injuries or ALS. To determine eligibility, individuals can join Neuralink's U.S. Patient Registry and learn more about the study by visiting "This collaboration is a significant step forward in finding solutions for millions living with motor deficits," said Marc Buoniconti, president of The Miami Project.
Yahoo
27-01-2025
- Health
- Yahoo
Elon Musk chooses Miami for Neuralink brain-implant research
Elon Musk's Neuralink has selected Miami as a clinical trial site for its brain-computer interface. Musk's Neuralink makes devices that link the human brain to computers, focusing on giving people with quadriplegia or paralysis the ability to control computers and devices with their thoughts. The Miami Project to Cure Paralysis and the Department of Neurological Surgery at the University of Miami will be the second U.S. site to participate in research known as the PRIME Study. Neuralink is already conducting clinical trials at Barrow Neurological Institute in Phoenix, Ariz. The company announced its first brain implant one year ago and announced earlier this month that a third person had received an implant. Patients who received the implants have been playing video games and online chess by simply thinking about steering left or right. For the PRIME Study, Neuralink scientists and a multidisciplinary team of neurosurgeons, neuroscientists and biomedical engineers at The Miami Project and the Miller School of Medicine will implant the device in local participants. Neuralink has already received approval from the U.S. Food and Drug Administration to launch an in-human clinical study. 'This collaboration represents another great opportunity to combine our clinical research expertise with the forward-thinking team at Neuralink,' said Marc Buoniconti, president of The Miami Project. 'We hope this partnership is another significant step in finding meaningful solutions for the millions living with paralysis and other significant motor deficits.' Buoniconti's father, Nick, an NFL Hall of Fame linebacker, founded The Miami Project in 1985 with neurosurgeon Barth Green after Marc suffered a spinal cord injury during a college football game that left him paralyzed from the shoulders down. Now in his 50s, Marc has turned his situation into purpose, raising funds for research and inspiring people with his drive to help people walk again. The Miami Project to Cure Paralysis at the University of Miami focuses on developing new strategies for repairing the nervous system and improving quality of life following spinal cord or brain injury. 'This study will use the latest technological advances in (brain-computer interfaces) approaches for improving function and quality of life in individuals living with the consequences of chronic spinal cord injury, as well as amyotrophic lateral sclerosis (ALS),' said Dr. Allan Levi, professor and chair of neurological surgery at the University of Miami. On its website, Neuralink says, 'We want to continuously improve our technologies based on learnings from clinical trials as we look to maximize the number of people we can potentially help.' For the PRIME Study, Neuralink is looking for patients who have limited or no ability to use both hands as a result of a cervical spinal cord injury or ALS. Additional details about the PRIME Study can be found on Individuals interested in learning whether they qualify for this trial can join Neuralink's United States Patient Registry.
